FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19480311000001104: Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Oct 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66099901000001115 Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
66100001000001119 Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Belimumab 400mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient Belimumab true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Benlysta true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has active ingredient Monoclonal antibody true Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial Has AMP True Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start